• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELLUME LIMITED COVID 19 HOME TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELLUME LIMITED COVID 19 HOME TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM Back to Search Results
Lot Number PF06QH
Device Problems Nonstandard Device (1420); Defective Device (2588)
Patient Problem Insufficient Information (4580)
Event Date 11/20/2021
Event Type  malfunction  
Event Description
Bought 4 ellume covid tests.On this date, all four were recalled as defective.On (b)(6) 2021 completed all the requested documentation to ellume to receive new tests.On (b)(6) 2021 ellume said would send replacement.They have sent only one replacement despite repeated requests.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVID 19 HOME TEST
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM
Manufacturer (Section D)
ELLUME LIMITED
MDR Report Key13505817
MDR Text Key285564991
Report NumberMW5107341
Device Sequence Number2
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 01/25/2022
4 Devices were Involved in the Event: 1   2   3   4  
1 Patient was Involved in the Event
Date FDA Received02/09/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Lot NumberPF06QH
Patient Sequence Number1
Treatment
BABY ASPIRIN ; CALCIUM; LOSARTAN; ROSUVASTATIN
Patient Age73 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-